Tag: psychedelics

Ketamine Therapy Is Now Being Offered Across the US by an Insurance Provider

Ketamine-assisted therapy is now available as a health benefit across the U.S.

Enthea, a benefits company focused on providing insurance coverage for psychedelic treatments, announced it is offering ketamine-assisted therapy to its benefit plans nationwide. The company already has ketamine-assisted therapy on benefit plans in California, New York, and Texas. 

But the number of Americans receiving this type of treatment as a benefit is limited. Currently only 1,500 people are offered it while the company hopes that number will reach 200,000 by the end of 2024. 

Ketamine is the only psychedelic that can legally be used to treat mental health conditions, and there’s been an influx of clinics offering the drug, sometimes in conjunction with psychotherapy, in the last few years. Sessions range from $300 to $1,500 a session without insurance—usually several sessions are recommended. 

Enthea’s ability to offer ketamine as a benefit nationwide is due to new partnerships with two companies—Skylight Psychedelics and Innerwell—that facilitate psychedelic experiences at clinics around the country, remotely, and in people’s homes, according to a news release. 

Employers looking to offer the benefit to its workers can add it on to existing plans, similarly to dental and vision plans, Enthea said. 

Keep reading

Key House Committee Clears Psychedelics Amendments To Defense Bill For Floor Votes, But Blocks Marijuana Proposals

A powerful House committee has cleared two psychedelics amendments for floor consideration as part of a large-scale spending bill covering the Department of Defense (DOD). But it also blocked separate marijuana-related proposals from advancing.

Several bipartisan members filed drug policy reform proposals that they hope will be attached to the Fiscal Year 2024 appropriations legislation. And on Tuesday, the House Rules Committee made the two psychedelics measures in order, allowing them to advance to floor votes.

The DOD bill is one of four spending packages on the committee’s current agenda, and all three of the remaining measures contain at least one marijuana proposal that would prohibit various departments from testing federal job applicants for cannabis.

Keep reading

CALIFORNIA MIGHT LEGALIZE MAGIC MUSHROOMS

A BILL TO legalize psychedelics is on a trip to California Gov. Gavin Newsom’s office.

On Thursday, the California Senate gave final approval to a bill legalizing certain psychedelics for people who are 21 or older. If Newsom signs the bill, it will go into effect in 2025 and make it legal to possess or grow plant-based psychedelics, including psychedelic mushrooms.

Newsom has not said where he stands on the bill, but he has mostly been a critic against the war on drugs, having been a leading voice to legalize cannabis in California and reduce nonviolent offenses like drug crimes to misdemeanors rather than felonies. Last year, however, he vetoed a bill that would have allowed three California cities to operate supervised drug-consumption sites in efforts to combat fatal overdoses.

“We respect the legislative process and don’t typically comment on pending legislation,” a Newsom spokesperson told Marijuana Moment on Thursday. “The governor will evaluate the bill on its merits when it reaches his desk.”

Keep reading

EXPLORING SEX AND PSYCHEDELICS

The connection between sex and psychedelics dates back to the sexual liberation movement throughout the 1960s and 70s. Psychedelics, in particular LSD, were associated with loosened sexual inhibitions and the resolution of past sexual trauma. Inspired by Timothy Leary’s infamous calls to ‘turn up, tune in, drop out’, psychedelics appeared as a tool for pleasure, love and self-expression. 

For sex guru Annie Sprinkle, using psychedelics through the 60s, 70s and 80s had profound positive impacts on her sex life. From opening doors to alternative realities, to increasing connectedness and sexual satisfaction between partners, Annie calls them her ‘greatest sexual educators’. 

She notes that the connection between sex and psychedelics is much deeper than arousal. Through each experience the user gains new information, allowing them to see themselves from a new perspective. This, in turn, can inform the individual’s sexual life.

Even though psychedelics remain illegal across much of the world, anecdotal evidence suggests that using psychedelics to enhance sexual experiences is still just as popular as it once was. However, as sex on drugs has inevitably been labelled a high-risk activity , there is a clear lack of hard-line statistics to back up such an assumption. 

Keep reading

Magic mushroom dispensaries multiplying in southwestern Ontario, with no cap in sight

Flying in the face of local law enforcement, a chain of illegal brick-and-mortar magic mushroom dispensaries with locations in London, Windsor, and across the province is expanding to more local municipalities, strengthening a trend reminiscent of the pre-legalization cannabis market.

A recently opened storefront in St. Thomas is the latest move for FunGuyz, the entity that runs at least 13 dispensaries in Canada and one in Detroit, with a spokesperson suggesting other nearby small towns may be next.

“We’re looking at Sarnia, Strathroy, smaller cities surrounding London,” said a spokesperson who identified themselves only as Edgar and said the St. Thomas store opened last week.

In the past, different spokespeople for the company have all identified themselves as Edgar, or Edgars Gorbans. When asked if the name was real by CBC Windsor in early August, one spokesperson claiming to be named Edgar Gorbans said  “could be,” and “of course not.”

The latest expansion comes despite recent police raids at FunGuyz stores. London Police raided the local store in early July, whereas Windsor Police have raided their local store multiple times, and issued an arrest warrant for the store’s owner, who they identified as Edward Gorbans. 

Keep reading

I Went to Rehab for Alcoholism 18 Times. Only Psychedelics Helped

I met Amanda at a pain therapy clinic in Zurich last December. She was sitting on a chair, hands folded neatly in her lap – she’d come here with her husband Tim for one of her regular visits to neurologist Livia Granata, one of the few specialists in Switzerland offering psychedelic therapy. 

British-born Amanda is 50 years old and has been an alcoholic for two decades. She also struggles with severe depression and anxiety stemming from childhood trauma. It took a lot for her to share her story, so she asked to be referred to on a first-name basis to protect her and her husband’s privacy. 

For the past seven years, Amanda hasn’t lived in her flat with her partner and their children, but outside on the balcony. She stays in an improvised shelter her husband made for her, only going in to use the toilet – and the pandemic only further tightened the grip her anxiety disorders have on her life.

A year ago, Amanda probably wouldn’t have shown up for this appointment at all, either cancelling at the last minute or simply letting it pass. Over the years, she’s been through too many treatments – experimental therapies that brought little to no relief. But in April 2022, she found her way to the clinic – and to the first treatment she felt ever truly worked.

Keep reading

“I’ve been here before”: DMT study explores a strange memory phenomenon

If you take a psychedelic drug that can throttle your conscious perception into an otherworldly space where people often report encountering beings that are unlike anything on Earth, the last thing you would expect to feel is the sense that this all seems pretty familiar. But that’s precisely what some people report after taking the world’s strongest psychedelic: DMT. 

“It felt like I had been reunited with everything, like I was complete again,” psychiatrist Dr. Chloe Sakal told Freethink in 2021 while describing a DMT experience she had as a participant in a study that examined the drug’s effects on the brain. “I no longer knew I was in an MRI scanner. My entire reality was very different — really colorful, really vibrant. And I couldn’t even remember that I was in a study. I was in a different dimension.”

Online reports from the r/DMT subreddit convey similarly intense and familiar experiences. “I was beyond time and matter and had no sense of identity whatsoever,” wrote one person. “I definitely felt this common thing like I was ‘at home,’ that I have already been there, and that I will go there again.”

Keep reading

The Return of MDMA

In 2006 a Florida man named Zulfi Riza reached out to Rick Doblin, the founder of the Multidisciplinary Association for Psychedelic Studies (MAPS). Riza was suicidal. He was suffering from PTSD, anxiety, depression, and anger issues. He had tried countless remedies, and he felt that Doblin was his last hope. Riza had heard that an underground network of psychiatrists practiced therapy using the illegal drug MDMA, better known as ecstasy or molly. And Doblin knew of such a therapist.

But Riza also suffered seizures. Should a medical emergency take place during a session, the therapist would be exposed and could lose their license, or worse.

Doblin told him he couldn’t help. Riza killed himself the very same morning.

The Drug Enforcement Administration (DEA) had unilaterally outlawed MDMA in 1985 under emergency powers granted to it by Congress. To back up the ban, the agency cited flimsy evidence about MDA, another drug entirely. It was a catastrophic case of government overreach. Zulfi Riza was just one of many people whose lives may have been saved had they not been forced to seek help in secret.

The DEA isn’t the only villain in this story. In 2002, a senator from Delaware named Joe Biden proposed the Reducing Americans’ Vulnerability to Ecstasy (RAVE) Act. This eventually passed, in somewhat watered-down form, as the Illicit Drug Anti-Proliferation Act. It basically made party organizers liable for drugs consumed on the premises. This made it much more complicated to organize services such as testing partygoers’ drugs for dangerous ingredients, as it would implicitly admit there was drug-taking on-site.

At a time when Americans are dying in record numbers from accidentally ingesting substances such as fentanyl, a de facto ban on drug checking in places where Americans take drugs—clubs, festivals—seems especially criminal.

Now that the war on weed is all but lost—federal legalization of marijuana feels like a matter of when, not if—the next battlefront will be over MDMA and other psychedelics. This year Australia allowed licensed therapists to give patients the drug. (It did the same as well for magic mushrooms.) Meanwhile, the Biden administration expects MDMA and psilocybin to be approved therapeutically within the next few years.

Keep reading

Psychoactive drug Psilocybin being studied for treatment of anorexia

Just a single dose of psilocybin was safe and tolerable for adult women with anorexia, according to a phase I open-label feasibility study.

After receiving a 25-mg dose of synthetic psilocybin given with therapist-delivered psychological support, none of the 10 participants experienced any significant changes in vital signs, ECGs, or suicidality during the week after dosing, reported Stephanie Knatz Peck, PhD, of the University of California San Diego, and colleagues.

Meeting the primary outcome, the treatment was also well-tolerated, with no serious adverse events reported amongst participants, who had an average body mass index (BMI) of 19.7, they noted in Nature Medicine.

As for changes in psychopathology — the secondary outcome of the early-stage trial — concerns about weight significantly decreased from baseline to 1 month after psilocybin treatment.

This improvement was also maintained up to 3 months after dosing. Likewise, shape concerns significantly dropped within the month after treatment, but this change was no longer significant at the 3-month mark.

Changes in eating concerns and dietary restraint didn’t reach statistical significance, but there was a trend towards an improvement in eating concerns at the 3-month follow-up.

Keep reading